Literature DB >> 2841862

Increased abundance of Na+-K+-ATPase mRNAs in response to low external K+.

T A Pressley1, F Ismail-Beigi, G G Gick, I S Edelman.   

Abstract

Exposure of ARL 15 cells, an established line from adult rat liver, to external K+ concentrations less than 1 mM for 24 h increases Na+-K+ pump abundance (Na+-K+-ATPase) (J. Gen. Physiol. 87:591-606, 1986). We found that treatment of confluent monolayers of ARL 15 cells with low-K+ medium (0.65 mM) caused a 100% increase in total RNA content per plate after 24 h, as well as a 25% increase in DNA and protein content per plate. Concomitant with this growth effect, low-K+ exposure for 6 h elicited 60% increases in mRNA alpha and mRNA beta, the mRNAs that encode the constituent subunits of the Na+-K+-ATPase, in a polyadenylated RNA fraction. At 24 h, however, the abundance of mRNA alpha increased by 290%, whereas mRNA beta increased by only 70%. Moreover, in both control and low-K+-treated cells, mRNA alpha was 30-fold or more greater in abundance than mRNA beta. This discrepancy in abundance was also present in rat liver, but not in cultured MDCK cells. The differences in abundance of mRNA alpha and mRNA beta suggest that the liver may have an unusual subunit composition or biosynthetic mechanism. Nevertheless, the increases in the abundance of mRNA alpha and mRNA beta are sufficient to account for the observed 70-100% increase in Na+-K+-ATPase activity in response to low external K+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841862     DOI: 10.1152/ajpcell.1988.255.2.C252

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Regulation of Na/K-ATPase beta1-subunit gene expression by ouabain and other hypertrophic stimuli in neonatal rat cardiac myocytes.

Authors:  P Kometiani; J Tian; J Li; Z Nabih; G Gick; Z Xie
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

2.  Stimulation of Na,K-ATPase by low potassium is dependent on transferrin.

Authors:  W Yin; G Jiang; K Takeyasu; X Zhou
Journal:  J Membr Biol       Date:  2003-06-01       Impact factor: 1.843

3.  Na(+) and K(+) allosterically regulate cooperative DNA binding by the human progesterone receptor.

Authors:  Keith D Connaghan; Aaron F Heneghan; Michael T Miura; David L Bain
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

4.  Thyroidal enhancement of rat myocardial Na,K-ATPase: preferential expression of alpha 2 activity and mRNA abundance.

Authors:  G G Gick; J Melikian; F Ismail-Beigi
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

Review 5.  Ion concentration-dependent regulation of Na,K-pump abundance.

Authors:  T A Pressley
Journal:  J Membr Biol       Date:  1988-11       Impact factor: 1.843

Review 6.  Regulation of Na+,K(+)-ATPase gene expression: a model to study terminal differentiation.

Authors:  G Celsi; Z M Wang
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  Na,K-ATPase expression in C2C12 cells during myogenesis: minimal contribution of alpha 2 isoform to Na,K transport.

Authors:  S C Higham; J Melikian; N J Karin; F Ismail-Beigi; T A Pressley
Journal:  J Membr Biol       Date:  1993-01       Impact factor: 1.843

8.  Role of enhanced Na+ entry in the control of Na,K-ATPase gene expression by serum.

Authors:  A Kirtane; N Ismail-Beigi; F Ismail-Beigi
Journal:  J Membr Biol       Date:  1994-01       Impact factor: 1.843

9.  Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.

Authors:  Dawn R Cochrane; Britta M Jacobsen; Keith D Connaghan; Erin N Howe; David L Bain; Jennifer K Richer
Journal:  Mol Cell Endocrinol       Date:  2012-01-18       Impact factor: 4.102

10.  Regulation of Na,K-adenosine triphosphatase gene expression by sodium ions in cultured neonatal rat cardiocytes.

Authors:  K Yamamoto; U Ikeda; Y Seino; Y Tsuruya; A Oguchi; K Okada; S Ishikawa; T Saito; K Kawakami; Y Hara
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.